GlycoSeLect specialises in the development and production of Recombinant Prokaryotic Lectins (RPLs), innovative technology for the analysis and purification of glycosylated biomolecules. RPLs have a broad spectrum of applications across the life sciences in:

•    Basic R&D – Glycobiology & Glycoproteomics.
•    Biomarker Discover & Biomedical Diagnostics.
•    The Biopharmaceutical Industry.
•    Vaccines
•    Cosmetics

GlycoSeLect's Recombinant Prokaryotic Lectins (RPLs) present significant advantages over existing commercially available lectins products including:
    
    •    Simplified, rapid & cost effective production through recombinant expression in Escherichia coli.
    •    High purity & consistent performance.
    •    Genetically enhanced glycan binding properties (specificity & affinity).
    •    Scalable production facilitating utilization for large scale applications.

For more information please visit our website at www.glycoselect.com

GlycoSeLect Ltd

Neil Brown

This department oversees the strategic direction and financial health of the organization.

Executive Leadership

This department focuses on advancing scientific knowledge and providing expert guidance in research and development initiatives.

GlycoSeLect Ltd

Org chart

Teams

Executive Leadership

Scientific Affairs

Offices

GlycoSeLect Ltd

Org chart

Teams

Executive Leadership

Scientific Affairs

Offices

Related companies